Iannone Robert
CIK 0001737329
EVP, Global Head of Research aDirector
Filings
20
Latest Mar 9, 2026
Issuers covered
3
Showing
20 of 20
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 100% | +17.2% | +21.4% | +23.0% | +3.0% |
| 90 days | 4 | 100% | +15.8% | +20.1% | +21.6% | +1.2% |
| 180 days | 4 | 75% | -4.8% | +5.1% | +5.5% | -35.0% |
| 365 days | 3 | 0% | -34.1% | -33.6% | -33.6% | -35.3% |
Issuers
Companies where Iannone Robert has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 15 | Mar 9, 2026 |
| ITOS | Iteos Therapeutics, Inc. | 3 | Jun 13, 2024 |
| JNCE | Jounce Therapeutics, Inc. | 2 | May 4, 2023 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|